Clik here to view.
Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early...
BEIJING Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests,...
View ArticleClik here to view.
Pudu Robotics Announces Newly Released Puductor2 to Improve Public Health Safety
SHENZHEN, China Pudo Robotics announced today the release of Puductor2, a technology-based, anti-pandemic robot. This newly designed intelligent robot has two disinfection modes of ultra-dry mist...
View ArticleClik here to view.
CureApp SC, Digital Therapeutic for Nicotine Addiction: Introducing a New...
TOKYO CureApp, Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Kohta Satake) has announced that CureApp SC Nicotine Addiction Treatment App and CO Checker (hereafter, CureApp SC) – a treatment app (digital...
View ArticleClik here to view.
研究比较机械通气患者液体反应性的两种无创指标，发现MasimoPVi®有效且具有优势
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布《艾因夏姆斯麻醉学杂志》发表的一项研究结果，该研究中，埃及开罗艾因夏姆斯大学(Ain-Shams University)的Diaaeldin Aboelnile博士及其同事比较两种评估机械通气患者液体反应性的无创方法dIVC和Masimo...
View ArticleClik here to view.
人工呼吸器患者におけ輸液反応の非侵襲的指標2種を比較した研究からMasimo PVi®の効果と利点が判明
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ：MASI）は本日、アインシャムス大学（エジプト、カイロ）のDr. Diaaeldin Aboelnileと同僚らがAin-Shams Journal of Anesthesiologyに発表した研究の結果を発表しました。この研究では、人工呼吸器患者におけ輸液反応を評価するための2つの非侵襲的方法、すなわちdIVCとMasimo...
View ArticleClik here to view.
TAITRA Launches Online Medical Show
TAIPEI, Taiwan Taiwan External Trade Development Council (TAITRA), the operator of the nation’s largest B2B portal Taiwantrade.com, has launched the 2020 Medical Online Show. This press release...
View ArticleClik here to view.
尼古丁成瘾的数字化疗法CureApp SC：推出基于App的新式处方治疗——首个将被纳入日本公共医保系统的数字化疗法
东京 (美国商业资讯)– CureApp, Inc.（总部：东京都中央区；首席执行官：Kohta Satake）宣布，经过一段时间的临床试验和监管审批，针对尼古丁成瘾的治疗App（数字化疗法）CureApp SC尼古丁成瘾治疗App和CO检查器（下称CureApp SC）现于2020年12月1日纳入日本公共医保系统。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Dr. M. Nasar Qureshi Named President of the American Pakistan Foundation
CRANFORD, N.J. Dr. M. Nasar Qureshi, President and Chief Medical Officer of QDx Pathology Services, a national, independent and full-service anatomical and molecular pathology laboratory, has been...
View ArticleClik here to view.
Sherlock Biosciences Strengthens Intellectual Property Portfolio in...
CAMBRIDGE, Mass. Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced exclusive license agreements with...
View ArticleClik here to view.
SUSMED Brings Greater Efficiencies in Clinical Trials by Using Blockchain...
TOKYO SUSMED, Inc., has announced that it has received word from both the Ministers of Health, Labor, and Welfare, and of Economy, Trade, and Industry that the monitoring process, which is...
View ArticleClik here to view.
Veristat Named Top Patient Recruitment Company 2020 by Pharma Tech Outlook
SOUTHBOROUGH, Mass. Veristat, a global clinical research organization, was named among the Top Patient Recruitment Companies of 2020 by Pharma Tech Outlook. With over 26 years’ experience partnering...
View ArticleClik here to view.
NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines...
ELMSFORD, N.Y. NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today...
View ArticleClik here to view.
Next Science and 3M Donate $300,000 of Breakthrough Wound Treatment to...
JACKSONVILLE, Fla. Next Science (ASX:NXS), an innovative medical technology company that is the leader in treating biofilm-based infections in humans, announced today that it has donated $300,000...
View ArticleClik here to view.
Mojo Vision and Menicon Announce Joint Development Agreement on Smart Contact...
SARATOGA, Calif. Mojo Vision, the Invisible Computing company, and Menicon, Japan’s first and largest contact lens manufacturer, today announced that both companies have entered into a joint...
View ArticleClik here to view.
D. One Vision Management Leads $16 Million Series A Investment In PrinterPrezz
NEW YORK D. One Vision Management with its DOV Singularity Fund, an alternative investment vehicle for investors seeking growth and diversification in tech-empowered future, today announced the...
View ArticleClik here to view.
Complimentary Ticket to Join YAFO ACCESS CHINA Forum 2021
SHANGHAI YAFO Life Science and BioToChina.org announced the schedule for ACCESS CHINA Forum 2021 (January 4th - 22nd). As the largest China corporate access event during the JPM Conference weeks,...
View ArticleClik here to view.
PROTEOR Group Becomes One of the Largest Prosthetic Providers in the World
TEMPE, Ariz. & DIJON, France Proteor, a France-based international group specialized in prosthetic and orthotic solutions, has successfully completed its acquisition of American brand Freedom...
View ArticleClik here to view.
D. One Vision Management领投PrinterPrezz 1600万美元A轮融资
纽约 D. One Vision Management及其旗下另类投资基金DOV Singularity Fund今天宣布已将全球首家医疗制造（MedifacturingTM）公司PrinterPrezz纳入其投资组合。该基金面向希望在科技赋能的未来实现财富增长和多元化的投资者。通过DOV Singularity Fund，D. One Vision...
View ArticleClik here to view.
新研究提示，Masimo SpHb®无创连续血红蛋白监测作为患儿血液管理的一部分，可减少ICU留住时间和术后输血
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布Euroanaesthesia 2020上最新呈报的一篇摘要的结果，该研究中，土耳其伊斯坦布尔马尔马拉大学的Saraçoğlu博士及其同事调查Masimo无创连续血红蛋白监测SpHb®作为接受大手术的患儿输血管理组成部分的有效性1。研究人员发现，使用SpHb可降低术后输血率、缩短ICU留住时间、改善其他转归。...
View ArticleClik here to view.
Researchers Use Masimo ORi™, Oxygen Reserve Index, to Help Suppress...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of an abstract recently presented at Euroanaesthesia 2020 in which Dr. Kumagai and colleagues at Iwate Medical University...
View Article